Blockchain products are decentralizing many industries; existing and upcoming projects have targeted the financial sector, education, marketing—pretty much everything. The benefit of this is that no centralized entity is able to have so much power that it impacts an entire industry.

But one more key benefit of this is that decentralization makes it impossible to crack down on something. Think about it: after the Silk Road bust, it became clear that plenty of black market transactions were relying on Bitcoin. Nonetheless, the governments couldn’t crack shut down on Bitcoin… because there is no way to do so. Similarly, any blockchain product that aims to decentralize an industry can be extremely difficult to crack down.

A new blockchain product, Shivom, is about to decentralize genetic research.

Genetic Research: Important Yet Vulnerable

Shivom is developing a platform where anyone can securely store their genomic data; additionally, Shivom is also providing a marketplace where anyone can sell his or her genomic data to companies. Shivom’s entire ecosystem could include a marketplace for pretty much everything health-related down the road.

So far, genetic research has been difficult and expensive. Accessing genomic data hasn’t been an easy task and many of the suppliers of this data have been located in just a handful of developed countries. Consequently, genetic research has always been vulnerable to the legal environment in a small number of countries. Hence, advancements in one of the most important and powerful medical frontiers have been limited.

Now, Shivom is paving a new path. As genomic data will be available for purchase on an open marketplace, accessing it is going to become easy, irrespective of where a researcher or research center is located. This holds a number of key benefits.

• Genetic research is extremely valuable and it can be used for both good and bad. Leaving the development of one the most important healthcare advancements in just a few hands is incredibly dangerous. Shivom’s genomic marketplace makes it possible to spread the control of genetic research and for any medical research center to play an important role in the advancement of genomic data.

• Since genetic research is primarily taking place in a handful of companies, legal limitations that vary depending on the viewpoints of different elected officials regularly impact this market and create a turbulent atmosphere for development. Few researchers or companies would want to invest in a venture that could potentially face limitation if a conservative party were to get elected. With Shivom, researchers and research centers across the world have the opportunity to participate in this incredibly important healthcare development. This decentralizes the advancement of genetic research to at least some extent and ensures that progress doesn’t cease based on the political environment in just a small number of countries.

Genetic research opens up one of the most important healthcare frontiers. Its results could genuinely unlock the cures of every disease and perhaps even the secret to immortality. Shivom is making it possible to ensure the advancement of genetic research isn’t centralized in a few hands in a few countries. It opens up the doors to advancing an extremely important field of healthcare research to the world.

Essential Links

🌐 Website: https://shivom.io/
💡 Whitepaper: https://shivom.io/files/Whitepaper.pdf
👨 ANN Thread: https://bitcointalk.org/index.php?topic=2365709.0
💻 Telegram: https://t.me/projshivom
⌚️ Token Sale: May 3

Connect with me:
https://bitcointalk.org/index.php?action=profile;u=1700741;sa=summary
https://steemit.com/@hatu – Follow for a new ICO analysis every day!
Twitter
Telegram Group – Keep up with ICOs